EGFR and neoplasm: Dysregulated EGFR/MAPK signaling pathway has been reported in a variety of human cancers mainly because it can lead to malignant transformation and tumor progression through increased cell proliferation, prolonged survival, angiogenesis, anti-apoptosis, invasion, and metastasis (12).